FibroGen And AstraZeneca Agree To Terminate Roxadustat Collaboration Agreement Entered On Jul. 30, 2013; FibroGen Regains All Rights To Roxadusta In United States And Other AstraZeneca Territories, Except China And South Korea
Author: Benzinga Newsdesk | February 26, 2024 05:06pm